The architecture of disease

2024-10-09T09:52:41+01:009 October 2024|

Our photo essay features some of the people behind the cutting-edge cancer research at the Sanger Institute. With genomic techniques now able to uncover the DNA sequence and structure in millions individual cells, they are uncovering the genetic architecture of disease.

Ambitious goals in autoimmune research

2024-05-14T21:12:48+01:0016 April 2024|

Sanger Excellence Fellow Dr Samantha Jumbe aims to understand the role of genetic mutations in autoimmune conditions like lupus, psoriasis and systemic liver disease.

From somatic mutations to Quotient

2024-07-05T10:10:12+01:0021 November 2023|

We spoke to Dr Iñigo Martincorena, group leader at the Wellcome Sanger Institute and academic co-founder of Quotient Therapeutics. Quotient is a new company leveraging Sanger Institute research to innovate the way drugs are discovered.

Four Institute researchers have made it to Reuters most influential list

2012-06-21T13:29:41+01:0021 June 2012|

Four of the Wellcome Trust Sanger Institute researchers been cited by Thomson Reuters as being among the top 15 most influential scientific researchers of 2011. Professor Mike Stratton, Dr Andy Futreal, Dr Peter Campbell and Dr Panos Deloukas, according to citations tracked during 2011, recorded some of the highest numbers of “Hot Papers” published over the preceding two years.